FDA Inspection 1167020 — Department Of Defense - Navy

Department Of Defense - Navy — FEI 1176560

The FDA completed an inspection of Department Of Defense - Navy on Mar 11, 2022 in Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Mar 11, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Bethesda, MD (United States)